Hemodynamic variables and mortality in cardiogenic shock: A retrospective cohort study

Critical Care

Volumn 13, Issue 5, 2009, Pages

  Torgersen, Christian ^a   Schmittinger, Christian A ^a   Wagner, Sarah ^b   Ulmer, Hanno ^a   Takala, Jukka ^b   Jakob, Stephan M ^b   Dünser, Martin W ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE;

AGE; AGED; ARTICLE; CARDIOGENIC SHOCK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART INDEX; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; ANALYSIS OF VARIANCE; MEDICAL AUDIT; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; SURVIVAL; SWITZERLAND;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COHORT STUDIES; FEMALE; HEMODYNAMICS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MEDICAL AUDIT; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SURVIVAL ANALYSIS; SWITZERLAND;

EID: 77949910125     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8114     Document Type: Article

References (29)

1. Petersen JW, Felker GM. Inotropes in the management of acute heart failure. Crit Care Med 2008, 36(1 Suppl):S106-111. 10.1097/01.CCM.0000296273.72952.39, 18158469.
2. El Mokhtari NE, Arlt A, Meissner A, Lins M. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine. Eur J Med Res 2008, 13:459-463.
3. Shoemaker WC, Appel PL, Kram HB, Duarte D, Harrier HD, Ocampo HA. Comparison of hemodynamic and oxygen transport effects of dopamine and dobutamine in critically ill surgical patients. Chest 1989, 96:120-126. 10.1378/chest.96.1.120, 2736968.
4. Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress. J Intensive Care Med 2009, 24:293-316. 10.1177/0885066609340519, 19703817.
5. Varga A, Garcia MA, Picano E, . International Stress Echo Complication Registry Safety of stress echocardiography. Am J Cardiol 2006, 98:541-543. 10.1016/j.amjcard.2006.02.064, 16893714, International Stress Echo Complication Registry.
6. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005, 352:539-548. 10.1056/NEJMoa043046, 15703419.
7. Abraham J, Mudd JO, Kapur NK, Klein K, Champion HC, Wittstein IS. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 2009, 53:1320-1325. 10.1016/j.jacc.2009.02.020, 19358948.
8. Silberbauer J, Hong P, Lloyd GW. Takotsubo cardiomyopathy (left ventricular apical abllooning syndrome) induced during dobutamine stress echocardiography. Eur J Echocardiogr 2008, 9:136-138.
9. Goldspink DF, Burniston JG, Ellison GM, Clark WA, Tan LB. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways?. Exp Physiol 2004, 89:407-416. 10.1113/expphysiol.2004.027482, 15131072.
10. Culling W, Penny WJ. Arrhythmogenic and electrophysiological effects of alpha adrenoreceptor stimulation during myocardial ischemia and reperfusion. J Mol Cell Cardiol 1987, 19:251-258. 10.1016/S0022-2828(87)80592-8, 3037089.
11. Reynolds HR, Hochman JS. Cardiogenic shock: Current concepts and improving outcomes. Circulation 2008, 117:686-697. 10.1161/CIRCULATIONAHA.106.613596, 18250279.
12. Mäkivirta A, Koski E, Kari A, Sukuvaara T. The median filter as a preprocessor for a patient monitor limit alarm system in intensive care. Comput Methods Programs Biomed 1991, 34:139-144. 10.1016/0169-2607(91)90039-V, 2060287.
13. Takala J, Dellinger RP, Koskinen K, St Andre A, Read M, Levy M, Jakob SM, Mello PV, Friolet R, Ruokonen E, . CPIC Study Group Development and simultaneous application of multiple care protocols in critical care: a multicenter feasibility study. Intensive Care Med 2008, 34:1401-1410. 10.1007/s00134-008-1084-x, 18385977, CPIC Study Group.
14. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.270.24.2957, 8254858.
15. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
16. Jakob SM, Korhonen I, Ruokonen E, Virtanen T, Kogan A, Takala J. Detection of artifacts in monitored trends in intensive care. Comput Methods Programs Biomed 2000, 63:203-209. 10.1016/S0169-2607(00)00110-3, 11064143.
17. Cotter G, Williams SG, Vered Z, Tan LB. Role of cardiac power in heart failure. Curr Opin Cardiol 2003, 18:215-222. 10.1097/00001573-200305000-00007, 12826823.
18. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999, 341:625-634. 10.1056/NEJM199908263410901, 10460813.
19. Faxon DP. Early reperfusion strategies after acute ST-segment elevation myocardial infarction: the importance of timing. Nat Clin Pract Cardiovasc Med 2005, 2:22-28. 10.1038/ncpcardio0065, 16265339.
20. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry. J Am Coll Cardiol 2004, 44:340-348. 10.1016/j.jacc.2004.03.060, 15261929.
21. Hasdai D, Holmes DR, Califf RM, Thompson TD, Hochman JS, Pfisterer M, Topol EJ. Cardiogenic shock complicating acute myocardial infarction: predictors of death. Am Heart J 1999, 138:21-31. 10.1016/S0002-8703(99)70241-3, 10385759.
22. Tan LB, Littler WA. Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and management. Br Heart J 1990, 64:121-128. 10.1136/hrt.64.2.121, 1024351, 2393609.
23. Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, Nabet P, Larcan A. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized trial. Intensive Care Med 1997, 23:282-287. 10.1007/s001340050329, 9083230.
24. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995, 333:1025-1032. 10.1056/NEJM199510193331601, 7675044.
25. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330:1717-1722. 10.1056/NEJM199406163302404, 7993413.
26. Luchette FA, Jenkins WA, Friend LA, Su C, Fischer JE, James JH. Hypoxia is not the sole cause of lactate production during shock. J Trauma 2002, 52:415-419. 10.1097/00005373-200203000-00001, 11901313.
27. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 2005, 365:871-875. 10.1016/S0140-6736(05)71045-X, 15752531.
28. Müller S, How OJ, Hermansen SE, Stenberg TA, Sager G, Myrmel T. Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia. Crit Care 2008, 12:R20. 10.1186/cc6794, 2374634, 18291025.
29. Schwertz H, Müller-Werdan U, Prondzinsky R, Werdan K, Buerke M. Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?. Dtsch Med Wochenschr 2004, 129:1925-1930. 10.1055/s-2004-831364, 15372372.